Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine Anti aging FOXO4 DRI explained ! The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications FOXO4 DRI: A Breakthrough Peptide Targeting Aging at Its Roots PARTICLE, s. r. o.
Shopping security
Each payment you make on thelockerguy is secured with strict SSL encryption and PCI DSS data protection protocols
product description
Why choose thelockerguy wholesale?
Show More
foxo4-dri cancer Using FOXO4-DRI to eradicate senescent cells | by Nina Khera